Results and prospects of development of new polyphenolic drugs for cancer patients

The conference "Results and prospects of development of new polyphenolic drugs for cancer patients" took place at the N.N. Petrov National Medical Research Center of Oncology (PNMRCO) on May 31, 2017, and gathered researchers involved in development and evaluation of medicinal products bas...

Full description

Saved in:
Bibliographic Details
Published inOncotarget Vol. 8; no. 59; pp. 100951 - 100956
Main Authors Anisimov, Vladimir N, Larsen, Stig, Lofberg, Stig, Baldueva, Irina A, Malek, Anastasia V, Nielsen, Tea Kirkegaard, Fedoros, Elena I, Perminova, Irina V, Drobyshev, Evgeny Yu, Bykov, Vladimir N, Panchenko, Andrey V, Scherbakov, Alexander M, Belyaev, Alexey M
Format Journal Article
LanguageEnglish
Published United States Impact Journals LLC 21.11.2017
Subjects
Meeting Report
clinical trial
polyphenols
breast cancer
cancer
cancer chemotherapy
Online AccessGet full text

Cover

More Information
Summary:The conference "Results and prospects of development of new polyphenolic drugs for cancer patients" took place at the N.N. Petrov National Medical Research Center of Oncology (PNMRCO) on May 31, 2017, and gathered researchers involved in development and evaluation of medicinal products based on the novel lignin-derived soluble polyphenolic polymer BP-Cx-1. BP-Cx-1 is the platform for a portfolio of innovative pharmacological products such as BP-C1, BP-C2 and BP-C3.
ISSN:1949-2553
1949-2553
DOI:10.18632/oncotarget.22307